Publicacions en col·laboració amb investigadors/es de Hospital de la Santa Creu i Sant Pau (14)

2021

  1. Author Correction: Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia (Scientific Reports, (2019), 9, 1, (16680), 10.1038/s41598-019-53209-y)

    Scientific Reports

2019

  1. Archeogenetics of F11 p.Cys38Arg: A 5400-year-old mutation identified in different southwestern European countries

    Blood

2017

  1. Clinical perspectives on the management of bleeding in patients on oral anticoagulants: The DECOVER Study (DElphi Consensus on oral COagulation and therapy action reVERsa

    Emergencias, Vol. 29, Núm. 1, pp. 18-26

  2. High incidence of FXI deficiency in a Spanish town caused by 11 different mutations and the first duplication of F11: Results from the Yecla study

    Haemophilia, Vol. 23, Núm. 6, pp. e488-e496

2016

  1. Antithrombin Dublin (p.Val30Glu): A relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency

    Thrombosis and Haemostasis, Vol. 116, Núm. 1, pp. 146-154

  2. Real-life management of primary immune thrombocytopenia (ITP) in adult patients and adherence to practice guidelines

    Annals of Hematology, Vol. 95, Núm. 7, pp. 1089-1098

2015

  1. The JAK2 46/1 haplotype does not predispose to CALR-mutated myeloproliferative neoplasms

    Annals of Hematology, Vol. 94, Núm. 5, pp. 789-794

  2. sST2 levels are associated with all-cause mortality in anticoagulated patients with atrial fibrillation

    European Journal of Clinical Investigation, Vol. 45, Núm. 9, pp. 899-905

2012

  1. Regulatory regions of SERPINC1 gene: Identification of the first mutation associated with antithrombin deficiency

    Thrombosis and Haemostasis, Vol. 107, Núm. 3, pp. 430-437

2011

  1. Novel loci involved in platelet function and platelet count identified by a genome-wide study performed in children

    Haematologica, Vol. 96, Núm. 9, pp. 1335-1343

2010

  1. Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm

    Nature Genetics, Vol. 42, Núm. 8, pp. 692-697

2009

  1. Antithrombin Cambridge ll (A384S) supports a role for antithrombin deficiency in arterial thrombosis

    Thrombosis and Haemostasis, Vol. 101, Núm. 3, pp. 483-486

2008

  1. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms

    Haematologica, Vol. 93, Núm. 5, pp. 729-734

2007

  1. Antithrombin Cambridge II (A384S): An underestimated genetic risk factor for venous thrombosis

    Blood, Vol. 109, Núm. 10, pp. 4258-4263